North America Cannabidiol (CBD) Market – Industry Trends and Forecast to 2029

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Cannabidiol (CBD) Market – Industry Trends and Forecast to 2029

  • Food & Beverage
  • Published Report
  • Aug 2022
  • North America
  • 350 Pages
  • No of Tables: 111
  • No of Figures: 43

North America Cannabidiol (CBD) Market By Source (Hemp And Marijuana), Grade (Food Grade And Therapeutics Grade), Nature (Organic And Inorganic), Application (Tincture, Food, Beverages, Pharmaceutical, Topicals, Dietary Supplements And Others), Product Type (CBD Oil, CBD Concentrates, CBD Isolates And Others) - Industry Trends and Forecast to 2029.

North America Cannabidiol (CBD) Market

North America Cannabidiol (CBD) Market Analysis and Insights

North America cannabidiol (CBD) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 28.7% in the forecast period of 2022 to 2029. Technological advancements in cannabidiol (CBD) drug treatments, rise in the healthcare sector are another factors drive growth of the North America cannabidiol (CBD) market in the forecast period.

North America Cannabidiol (CBD) Market

North America Cannabidiol (CBD) Market

However, side effects associated with CBD oil and counterfeit and synthetic products available in the market will restraining the market growth. Adoption of strategic alliances like partnerships and acquisitions by key market players act as an opportunity for the growth of North America cannabidiol (CBD) market.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019-2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Source (Hemp And Marijuana), Grade (Food Grade And Therapeutics Grade), Nature (Organic And Inorganic), Application (Tincture, Food, Beverages, Pharmaceutical, Topicals, Dietary Supplements And Others), Product Type (CBD Oil, CBD Concentrates, CBD Isolates And Others)  

Countries Covered

U.S., Canada, Mexico

Market Players Covered

Some of the key players operating in the North America cannabidiol (CBD) market are CV Sciences, Inc., VIVO Cannabis Inc., Gaia Herbs Hemp, Phoena Holdings Inc., Medical Marijuana, Inc., The Cronos Group, CHARLOTTE’S WEB, HEXO Corp., Aurora Cannabis, Canopy Growth Corporation, Jazz Pharmaceuticals, Inc., Tilray, Curaleaf, KAZMIRA, Freedom Leaf, Inc., Koi CBD, Groff North America Hemplex, Joy Organics, Elixinol Wellness Limited, Isodiol International Inc., Healthy Food Ingredients, LLC, NuLeaf Naturals, LLC, Diamond CBD, Medterra CBD, ENDOCA, Green Roads among others.

Cannabidiol (CBD) Market Definition

Cannabidiol (CBD) is a chemical compound that is found in the cannabis sativa plant, and is extracted from hemp or cannabis, generally from hemp due to its naturally high cannabidiol (CBD) content. It has several benefits in treating anxiety and seizures and reducing pain. Due to its healing properties, the demand for CBD for health and wellness purposes is high, which is the major factor driving the market. Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation. Due to the increasing adoption of CBD-based products to treat ailments, the North America market is anticipated to grow at a lucrative rate over the forecast period. Cannabidiol oil is increasingly being used to make skincare products to treat acne and wrinkles. Sephora, for example, had recently introduced cannabidiol or CBD skincare line to its stores. Similarly, Ulta Beauty is intending to launch a cannabidiol-based product line. Several new companies are also entering the market for cannabidiol-infused cosmetic products.

Furthermore, the government of different countries as well as major players in the cannabinoid market are investing in research and development activities. The CBD is said to be an effective treatment for various neurological diseases including epilepsy in several clinical trials.

Market Dynamics                                        

Drivers

  • Increasing demand for CBD in health & fitness

Rising awareness among consumers regarding health and fitness will help CBD market to witness rapid growth. Increasing consumer disposable income along with the legalization of medicinal cannabis is anticipated to have a positive impact on the demand for cannabidiol in this sector.

Moreover, CBD products are used to relieve various problems such as anxiety/ stress, sleep/insomnia, chronic pain, migraine, skin care, seizures, joint pain & inflammation, neurological conditions, and many others. The chronic pain treatment has gained much popularity due to additional benefits offered by CBD when used. There has been increasing demand for cannabidiol (CBD) products over recent years owing to its widespread medical applications and pain relief treatment. CBD helps in reducing chronic pain by acting on variety of biological process in the body. In addition, CBD possesses antioxidant, anti-inflammatory and analgesic properties. Therefore, CBD products reduces the anxiety that is experienced by the people suffering from the chronic pain. Thus, the increasing demand for CBD in the treatment of chronic pain is augmenting the market to grow. This also help people to maintain their health and fitness routines, while staying away from pain that may occur during fitness activities.

  • Improving government approvals and regulations for CBD products

There are strict government regulations and CBD based products required strict approvals before they were marketed and supplied in the local as well international market, which limited the growth of the market. However, with time these restrictions have been eased up and there has been increasing acceptance of refined CBD products combined with the increasing legalization of marijuana and marijuana-derived products for various applications. This will drive the growth and demand in the market.

Moreover, there is the presence of major manufacturers of CBD products across the globe which has further induced the government and other regulatory bodies such as Food and Drug Administration (F.D.A.) in the U.S., European Union in Europe, etc. to ease up the restrictions for CBD and CBD based products.

Restraint

  • High cost of CBD products

CBD is a popular and a holistic choice for people struggling with pain, inflammation, and sleep problems. Since CBD is a new product with less research and development and has lately been regulated and approved, therefore, the price of CBD are subject to fluctuations. The production of hemp became legal in 2018, which affected the price of CBD products. As a result, various CBD products witnessed some price inflation.

Moreover, many farmers are transitioning towards growing and selling hemp used to make CBD products, but despite the increased popularity of this product, it presents its own agricultural challenges. Firstly, switching over to a new crop results in new expenses. The most efficient way to harvest hemp is using a combine harvester. However, farmers who have previously grown crops that don’t require combines, such as strawberries, can’t afford to purchase a combine right away. Therefore, they need to hire people to help harvest the hemp, which drives up overall product prices as the raw material becomes costly.

Additionally, hemp requires more time and labor to grow and farmers need to inspect their crop closely as it grows. Furthermore, once it is harvested, extracting the cannabidiol is a difficult and expensive process. The processors and extractors of CBD need to use either ethanol or supercritical carbon dioxide (CO2 extraction). The extraction and refinement process requires special machinery and takes a long time, which drives up the CBD cost. Thus, all these factors add up to the costs of CBD products making them much more costly than other products, which is likely to restrain the market’s demand.

Opportunity

  • Increasing investments in development of new CBD based products

With the increasing trend of providing innovative and refined products in the market, manufacturers are spending large amounts in research and development for the production of new CBD based products. Oils, tinctures, concentrate, capsules, topical solutions such as slaves, lip balms, lotions, and edibles such as baked goods, coffee, chocolates, gums, and candies are some of the CBD products which are in high demand.

The increasing demand has increased the number of trials to study the impact of CBD on certain health conditions, which is expected to develop new products in turn providing opportunity for the rise in the demand in the forthcoming years. Furthermore, many companies procure CBD oils in bulk and manufacture CBD-infused products. In addition, numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance.

Moreover, with the ease in regulations and post the approval of cannabis products, the companies are investing huge amounts in the product development and upgrading the raw material production, which will also help them to cut down on costs while meeting the surging demand in the market. The new product development and increasing research and development activities along with various strategic decisions taken by key manufacturers in the market will offer lucrative opportunity for the growth of the North America CBD market.

Challenge

  • Side effects associated with CBD oil

Cannabidiol is well-known for its ability to cure a variety of illnesses, including anxiety, seizures, neurological problems, cancer-related nausea, chronic pain, and more. However, being useful for a variety of medical illnesses, various studies and research conducted by numerous organizations have shown that CBD-based medicines can have negative effects as well.

Some of the side effects that are commonly experienced by consumers include dry mouth, drowsiness, low blood pressure, and lightheadedness. CBD is also known to raise the level of Coumadin (a blood thinner) in the body, which can interact with other drugs and cause negative side effects. These factors might impede future adoption of CBD for therapeutic purposes.

Moreover, another cause for concern is the unreliability of the purity and dosage of CBD in products such as CBD oil. High concentration of CBD oil can also have harmful effects on the consumers’ health. In some cases, excessive use of CBD oil may also increase liver enzymes, which is a marker of liver inflammation. Cytochrome P450 (CYP450) is an enzyme which body uses to break down some drugs. CBD oil can block CYP450. That means that taking CBD oil with these drugs could make them have a stronger effect than one needs or make them not work at all.

Further, dietary supplements that contain CBD and a blend of herbal ingredients may not be safe for everyone, as many herbs have the potential to interact with commonly prescribed medications. All these side effects may vary from person to person as minor side effects for some may prove to be serious for others. This may pose as a challenge for the increasing demand of CBD products in the North America CBD market.

Post COVID-19 Impact on North America cannabidiol (CBD) market

COVID-19 has resulted in a substantial upsurge in demand for medical supplies from both healthcare professionals and the general public for precautionary measures. Manufacturers of these items have an opportunity to take advantage of the increased demand for medical supplies by ensuring a steady supply of personal protective equipment on the market. COVID-19 is anticipated to have a big impact on the North America cannabidiol (CBD) market.

North America cannabidiol (CBD) market Scope and Market Size

North America cannabidiol (CBD) market is segmented on the basis source, grade, application, product type, nature. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the Difference in your target markets.

BY SOURCE

  • HEMP
  • MARIJUANA

On the basis of source, the North America cannabidiol (CBD) market is segmented into hemp and marijuana.

BY PRODUCT TYPE

  • CBD OIL
  • CBD ISOLATES
  • CBD CONCENTRATES
  • OTHERS

On the basis of product type, the North America cannabidiol (CBD) market is segmented into CBD oil, CBD concentrates, CBD isolates and others

BY NATURE

  • ORGANIC
  • INORGANIC

On the basis of nature, the North America cannabidiol (CBD) market is segmented into organic and inorganic.

BY GRADE

  • FOOD GRADE
  • THERAPEUTIC GRADE

On the basis of grade, the North America cannabidiol (CBD) market is segmented into food grade and therapeutics grade.

BY APPLICATION

  • Tincture
  •  Food
  •  Beverages
  • Pharmaceutical
  • Topicals
  • Dietary supplements
  • Others

On the basis of application, the North America cannabidiol (CBD) market is segmented into tincture, food, beverages, pharmaceutical, topicals, dietary supplements and others.

Cannabidiol (CBD) Market

North America cannabidiol (CBD) market Country Level Analysis

The cannabidiol (CBD) market is analyzed and market size information is provided by source, grade, application, product type & nature.

The countries covered in the cannabidiol (CBD) market report are U.S., Canada and Mexico.

In 2022, U.S. is dominating due to the presence of key market players along the largest consumer market with high GDP. U.S is expected to grow due to rise in technological advancement in drug treatments.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Cannabidiol (CBD) market also provides you with detailed market analysis for every country growth in healthcare industry. Moreover, it provides detailed information regarding healthcare services and treatments, impact of regulatory scenarios, and trending parameters regarding cannabidiol (CBD) market.

Competitive Landscape and North America cannabidiol (CBD) market Share Analysis

North America cannabidiol (CBD) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to cannabidiol (CBD) products.

The major companies which are dealing in the cannabidiol (CBD) market are CV Sciences, Inc., VIVO Cannabis Inc., Gaia Herbs Hemp, Phoena Holdings Inc., Medical Marijuana, Inc., The Cronos Group, CHARLOTTE’S WEB, HEXO Corp., Aurora Cannabis, Canopy Growth Corporation, Jazz Pharmaceuticals, Inc., Tilray, Curaleaf, KAZMIRA, Freedom Leaf, Inc., Koi CBD, Groff North America Hemplex, Joy Organics, Elixinol Wellness Limited, Isodiol International Inc., Healthy Food Ingredients, LLC, NuLeaf Naturals, LLC, Diamond CBD, Medterra CBD, ENDOCA, Green Roads among others.

Strategic alliances like mergers, acquisitions and agreement by the key market players are further expected to accelerate the growth of cannabidiol (CBD) products.

For instance,

  • In May, 2022, Canopy Growth Corporation and Lemurian, Inc., a California-based producer of high-quality cannabis extracts and pioneer of clean vape technology, announced that they have entered into definitive agreements providing Canopy Growth, by way of a wholly-owned subsidiary, the right to acquire, upon federal permissibility of THC in the U.S. or earlier at Canopy Growth’s election, up to 100% of the outstanding capital stock of Jetty.This has helped the company to expand their business in market.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA CANNABIDIOL (CBD) MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 SOURCE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 BENCHMARKING ANALYSIS

4.2 CBD PRODUCTS, INCLUDING CANNABINOIDS (IN %)

4.3 CBD RAW MATERIAL DEVELOPMENT TREND

4.3.1 MORE CONTROLLED CBD LEVELS:

4.3.2 CBD AND GENETICS:

4.3.3 ADVANCEMENTS MADE IN EXTRACTION:

4.3.4 NANOTECHNOLOGY

4.3.5 CONCLUSION

4.4 COMPANY POSITIONING GRID

4.4.1 NORTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY LANDSCAPE

4.4.1.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

4.4.1.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

4.4.1.3 COMPANY SHARE ANALYSIS: EUROPE

4.4.1.4 COMPANY SHARE ANALYSIS: SOUTH AMERICA

4.4.2 COMPANY’S CURRENT VENDORS

4.5 OVERALL VOLUME (KILO TONS) & QUANTITY OF COMPLETED TRANSACTIONS: NORTH AMERICA CANNABIDIOL (CBD) MARKET

4.6 LIST OF COUNTRIES THAT LEGALIZED CANNABIDIOL (CBD)

4.7 REGULATION COVERAGE

4.8 IMPORT & EXPORT REGULATION

4.8.1 IMPORT REGULATIONS

4.8.2 EXPORT REGULATIONS

4.9 IMPORT STANDARDS

4.1 GOVERNMENT POLICIES

4.11 QUALIFICATION/CERTIFICATION REQUIRED

4.12 NORTH AMERICA CANNABIDIOL (CBD) MARKET: PRICING ANALYSIS & DEAL PRICING

4.13 RAW MATERIAL EXTRACTOR POSITIONING GRID

4.13.1 KEY EXTRACTION

4.13.2 LINE CAPABILITY

4.14 TECHNOLOGICAL ADVANCEMENTS:

4.15 VENDOR/ DISTRIBUTOR SHARE ANALYSIS

4.16 VENDOR/DISTRIBUTOR KEY BUYERS

5 CLIMATE CHANGE SCENARIO: NORTH AMERICA CANNABIDIOL (CBD) MARKET

5.1 ENVIRONMENT CONCERNS-

5.2 INDUSTRY RESPONSE-

5.3 GOVERNMENT INITIATIVES

5.4 ANALYST RECOMMENDATIONS

6 SUPPLY CHAIN OF THE NORTH AMERICA CANNABIDIOL (CBD) MARKET

6.1 LOGISTIC COST SCENARIO

6.2 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASE IN DEMAND FOR CBD IN HEALTH & FITNESS

7.1.2 IMPROVING GOVERNMENT APPROVALS AND REGULATIONS FOR CBD PRODUCTS

7.1.3 THERAPEUTIC PROPERTIES OF CBD OIL

7.1.4 CONSUMERS' SHIFT TOWARDS LEGALLY PURCHASING CANNABIS FOR MEDICAL AS WELL AS RECREATIONAL USE

7.2 RESTRAINTS

7.2.1 HIGH COST OF CBD PRODUCTS

7.2.2 AVAILABILITY OF COUNTERFEIT AND SYNTHETIC PRODUCTS IN THE MARKET

7.3 OPPORTUNITIES

7.3.1 INCREASING INVESTMENTS IN THE DEVELOPMENT OF NEW CBD BASED PRODUCTS

7.3.2 GROWING MEDICAL APPLICATIONS OF CBD

7.4 CHALLENGES

7.4.1 SIDE EFFECTS ASSOCIATED WITH CBD OIL

7.4.2 BARRIERS IN TERMS OF MARKETING OF CBD

8 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY SOURCE

8.1 OVERVIEW

8.2 HEMP

8.3 MARIJUANA

9 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE

9.1 OVERVIEW

9.2 CANNABIDIOL (CBD) OIL

9.2.1 CARBON DIOXIDE EXTRACTION

9.2.2 STEAM DISTILLATION

9.2.3 SOLVENT EXTRACTION

9.2.4 OTHERS

9.3 CANNABIDIOL (CBD) ISOLATES

9.4 CANNABIDIOL (CBD) CONCENTRATES

9.5 OTHERS

10 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY NATURE

10.1 OVERVIEW

10.2 ORGANIC

10.3 INORGANIC

11 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY GRADE

11.1 OVERVIEW

11.2 FOOD GRADE

11.3 THERAPEUTIC GRADE

12 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY APPLICATION

12.1 OVERVIEW

12.2 TINCTURE

12.3 FOOD

12.3.1 CHOCOLATE & CONFECTIONERY

12.3.1.1 CANDY

12.3.1.2 CHOCOLATE

12.3.1.3 CHEWS

12.3.1.4 GUMMIES

12.3.1.5 OTHERS

12.3.2 HONEY

12.3.3 DAIRY BASED EDIBLE

12.3.3.1 MILK

12.3.3.2 ICE CREAM

12.3.3.3 OTHERS

12.3.4 SAUCES AND SEASONINGS

12.3.5 BAKERY EDIBLE

12.3.5.1 COOKIES AND BISCUITS

12.3.5.2 BROWNIES

12.3.5.3 OTHERS

12.3.6 OTHERS

12.3.7 PHARMACEUTICALS

12.3.7.1 DRAVET SYNDROME

12.3.7.2 MULTIPLE SCLEROSIS DRUG APPLICATIONS

12.3.7.3 NEUROLOGICAL DRUG APPLICATIONS

12.3.7.4 CANCER DRUG APPLICATIONS

12.3.7.5 OTHERS

12.3.8 DIETARY SUPPLEMENTS

12.3.8.1 CAPSULES

12.3.8.2 GUMMIES

12.3.8.3 OTHERS

12.3.9 BEVERAGES

12.3.9.1 NON-ALCOHOLIC BEVERAGES

12.3.9.1.1 ENERGY DRINKS

12.3.9.1.2 SOFT DRINKS

12.3.9.1.3 RTD COFFEE

12.3.9.1.4 TEA

12.3.9.1.5 SPARKLING WATER

12.3.9.1.6 OTHERS

12.3.9.2 FLAVORED DRINKS

12.3.9.2.1 ORANGE

12.3.9.2.2 LEMON

12.3.9.2.3 BERRIES

12.3.9.2.4 COCONUT

12.3.9.2.5 OTHERS

12.3.9.3 ALCOHOLIC BEVERAGES

12.3.9.3.1 BEER

12.3.9.3.2 WINE

12.3.9.3.3 OTHERS

12.3.9.4 OTHERS

12.3.10 TOPICAL

12.3.10.1 LOTION

12.3.10.2 SALVE

12.3.10.3 LIP BALM

12.3.10.4 OTHERS

12.3.11 OTHERS

12.3.11.1 VAPES

12.3.11.2 CIGARETTES

12.3.11.3 SPA AND RECREATION

13 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY REGION

13.1 NORTH AMERICA

13.1.1 U.S.

13.1.2 CANADA

13.1.3 MEXICO

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 CURALEAF

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 TILRAY

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 JAZZ PHARMACEUTICALS, INC.

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENT

15.4 CANOPY GROWTH CORPORATION

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENTS

15.5 AURORA CANNABIS.

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 CHARLOTTE’S WEB.

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 CV SCIENCES, INC.

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENTS

15.8 DIAMOND CBD.

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENTS

15.9 ELIXINOL WELLNESS LIMITED

15.9.1 COMPANY SNAPSHOT

15.9.2 REVENUE ANALYSIS

15.9.3 PRODUCT PORTFOLIO

15.9.4 RECENT DEVELOPMENTS

15.1 ENDOCA.

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENT

15.11 FREEDOM LEAF, INC

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 GAIA HERBS HEMP

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 GREEN ROADS.

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

15.14 GROFF NORTH AMERICA HEMPLEX

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 HEXO CORP.

15.15.1 COMPANY SNAPSHOT

15.15.2 REVENUE ANALYSIS

15.15.3 PRODUCT PORTFOLIO

15.15.4 RECENT DEVELOPMENTS

15.16 HEALTHY FOOD INGREDIENTS, LLC.

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

15.17 ISODIOL INTERNATIONAL INC

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENTS

15.18 JOY ORGANICS

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENTS

15.19 KAZMIRA

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENTS

15.2 KOI CBD

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENTS

15.21 MEDICAL MARIJUANA, INC.

15.21.1 COMPANY SNAPSHOT

15.21.2 EVENUE ANALYSIS

15.21.3 PRODUCT PORTFOLIO

15.21.4 RECENT DEVELOPMENTS

15.22 MEDTERRA CBD

15.22.1 COMPANY SNAPSHOT

15.22.2 PRODUCT PORTFOLIO

15.22.3 RECENT DEVELOPMENTS

15.23 NULEAF NATURALS, LLC

15.23.1 COMPANY SNAPSHOT

15.23.2 PRODUCT PORTFOLIO

15.23.3 RECENT DEVELOPMENTS

15.24 PHOENA HOLDINGS INC.

15.24.1 COMPANY SNAPSHOT

15.24.2 PRODUCT PORTFOLIO

15.24.3 RECENT DEVELOPMENTS

15.25 THE CRONOS GROUP

15.25.1 COMPANY SNAPSHOT

15.25.2 REVENUE ANALYSIS

15.25.3 PRODUCT PORTFOLIO

15.25.4 RECENT DEVELOPMENTS

15.26 VIVO CANNABIS INC.

15.26.1 COMPANY SNAPSHOT

15.26.2 REVENUE ANALYSIS

15.26.3 PRODUCT PORTFOLIO

15.26.4 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

List of Table

TABLE 1 BENCHMARK ANALYSIS

TABLE 2 AVERAGE VOLUME TREND FOR NORTH AMERICA CANNABIDIOL (CBD) MARKET (KILO TONS)

TABLE 3 THE FOLLOWING ARE THE PRICES OF PRODUCTS OFFERED BY THE COMPANIES:

TABLE 4 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 5 NORTH AMERICA HEMP IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 NORTH AMERICA MARIJUANA IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 8 NORTH AMERICA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 NORTH AMERICA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)

TABLE 10 NORTH AMERICA CANNABIDIOL (CBD) ISOLATES IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 NORTH AMERICA CANNABIDIOL (CBD) CONCETRATES IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 NORTH AMERICA OTHERS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)

TABLE 14 NORTH AMERICA ORGANIC IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 NORTH AMERICA INORGANIC IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)

TABLE 17 NORTH AMERICA FOOD GRADE IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 NORTH AMERICA THERAPEUTIC GRADE IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 20 NORTH AMERICA TINCTURE IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 NORTH AMERICA FOOD IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 NORTH AMERICA FOOD IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)

TABLE 23 NORTH AMERICA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 24 NORTH AMERICA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 25 NORTH AMERICA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 26 NORTH AMERICA PHARMACEUTICALS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 NORTH AMERICA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 28 NORTH AMERICA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 NORTH AMERICA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 30 NORTH AMERICA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 NORTH AMERICA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 32 NORTH AMERICA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 33 NORTH AMERICA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 34 NORTH AMERICA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 35 NORTH AMERICA TOPICAL IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 NORTH AMERICA TOPICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 37 NORTH AMERICA OTHERS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 NORTH AMERICA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 39 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 40 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 41 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 42 NORTH AMERICA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)

TABLE 43 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)

TABLE 44 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)

TABLE 45 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 46 NORTH AMERICA FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 47 NORTH AMERICA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 48 NORTH AMERICA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 49 NORTH AMERICA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 50 NORTH AMERICA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 51 NORTH AMERICA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 52 NORTH AMERICA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 53 NORTH AMERICA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 NORTH AMERICA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 55 NORTH AMERICA TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 56 NORTH AMERICA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 57 NORTH AMERICA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 58 U.S. CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 59 U.S. CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 60 U.S. CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)

TABLE 61 U.S. CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)

TABLE 62 U.S. CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)

TABLE 63 U.S. CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 64 U.S. FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 65 U.S. CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 66 U.S. BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 67 U.S. DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 68 U.S. BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 69 U.S. ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 70 U.S. NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 71 U.S. FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 72 U.S. PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 73 U.S. TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 74 U.S. DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 75 U.S. OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 76 CANADA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 77 CANADA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 78 CANADA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)

TABLE 79 CANADA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)

TABLE 80 CANADA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)

TABLE 81 CANADA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 82 CANADA FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 83 CANADA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 84 CANADA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 85 CANADA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 86 CANADA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 87 CANADA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 88 CANADA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 89 CANADA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 90 CANADA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 91 CANADA TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 92 CANADA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 93 CANADA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 94 MEXICO CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 95 MEXICO CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 96 MEXICO CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)

TABLE 97 MEXICO CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)

TABLE 98 MEXICO CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)

TABLE 99 MEXICO CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 100 MEXICO FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 101 MEXICO CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 MEXICO BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 103 MEXICO DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 MEXICO BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 105 MEXICO ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 106 MEXICO NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 107 MEXICO FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 108 MEXICO PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 109 MEXICO TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 110 MEXICO DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 111 MEXICO OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)

List of Figure

FIGURE 1 NORTH AMERICA CANNABIDIOL (CBD) MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA CANNABIDIOL (CBD) MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA CANNABIDIOL (CBD) MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA CANNABIDIOL (CBD) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 NORTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA CANNABIDIOL (CBD) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA CANNABIDIOL (CBD) MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 NORTH AMERICA CANNABIDIOL (CBD) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA CANNABIDIOL (CBD) MARKET: SEGMENTATION

FIGURE 10 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NORTH AMERICA CANNABIDIOL (CBD) MARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 11 THE INCREASING DEMAND FOR CANNABIDIOL (CBD) DUE TO ITS HEALING PROPERTIES AND HEALTH AND WELLNESS PURPOSES IS HIGH, WHICH IS THE MAJOR FACTOR DRIVING THE MARKET IS EXPECTED TO DRIVE THE NORTH AMERICA CANNABIDIOL (CBD) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 HEMP IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CANNABIDIOL (CBD) MARKET IN 2022 & 2029

FIGURE 13 NORTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)

FIGURE 14 NORTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)

FIGURE 15 EUROPE CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)

FIGURE 16 SOUTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)

FIGURE 17 NORTH AMERICA CANNABIDIOL (CBD) MARKET: VENDOR/ DISTRIBUTOR SHARE ANALYSIS (%)

FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA CANNABIDIOL (CBD) MARKET

FIGURE 19 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY SOURCE, 2021

FIGURE 20 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY SOURCE, 2022-2029 (USD MILLION)

FIGURE 21 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY SOURCE, CAGR (2022-2029)

FIGURE 22 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY SOURCE, LIFELINE CURVE

FIGURE 23 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, 2021

FIGURE 24 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)

FIGURE 25 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, CAGR (2022-2029)

FIGURE 26 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 27 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY NATURE, 2021

FIGURE 28 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY NATURE, 2022-2029 (USD MILLION)

FIGURE 29 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY NATURE, CAGR (2022-2029)

FIGURE 30 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY NATURE, LIFELINE CURVE

FIGURE 31 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY GRADE, 2021

FIGURE 32 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY GRADE, 2022-2029 (USD MILLION)

FIGURE 33 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY GRADE, CAGR (2022-2029)

FIGURE 34 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY GRADE, LIFELINE CURVE

FIGURE 35 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY APPLICATION, 2021

FIGURE 36 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 37 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 38 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 39 NORTH AMERICA CANNABIDIOL (CBD) MARKET: SNAPSHOT (2021)

FIGURE 40 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY COUNTRY (2021)

FIGURE 41 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY COUNTRY (2022 & 2029)

FIGURE 42 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY COUNTRY (2021 & 2029)

FIGURE 43 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY SOURCE (2022-2029)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.